These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationship of treatment-resistant head lice to the safety and efficacy of pediculicides. Burkhart CG. Mayo Clin Proc; 2004 May; 79(5):661-6. PubMed ID: 15132409 [Abstract] [Full Text] [Related]
6. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. Chosidow O, Giraudeau B, Cottrell J, Izri A, Hofmann R, Mann SG, Burgess I. N Engl J Med; 2010 Mar 11; 362(10):896-905. PubMed ID: 20220184 [Abstract] [Full Text] [Related]
7. Lice and Scabies: Treatment Update. Gunning K, Kiraly B, Pippitt K. Am Fam Physician; 2019 May 15; 99(10):635-642. PubMed ID: 31083883 [Abstract] [Full Text] [Related]
8. Treatment of head lice. Diamantis SA, Morrell DS, Burkhart CN. Dermatol Ther; 2009 May 15; 22(4):273-8. PubMed ID: 19580574 [Abstract] [Full Text] [Related]
12. Scabies and pediculosis pubis: an update of treatment regimens and general review. Wendel K, Rompalo A. Clin Infect Dis; 2002 Oct 15; 35(Suppl 2):S146-51. PubMed ID: 12353201 [Abstract] [Full Text] [Related]
13. Therapy for head lice based on life cycle, resistance, and safety considerations. Lebwohl M, Clark L, Levitt J. Pediatrics; 2007 May 15; 119(5):965-74. PubMed ID: 17473098 [Abstract] [Full Text] [Related]
14. Ivermectin versus malathion for head lice. Rutman H. N Engl J Med; 2010 Jun 24; 362(25):2426-7; author reply 2427. PubMed ID: 20573934 [No Abstract] [Full Text] [Related]
17. Permethrin and malathion resistance in head lice: results of ex vivo and molecular assays. Bouvresse S, Berdjane Z, Durand R, Bouscaillou J, Izri A, Chosidow O. J Am Acad Dermatol; 2012 Dec 24; 67(6):1143-50. PubMed ID: 22627039 [Abstract] [Full Text] [Related]